Yahoo Web Search

Search results

    • Why Is Verastem (VSTM) Stock Down 62% Today?

      Why Is Verastem (VSTM) Stock Down 62% Today?

      InvestorPlace· 5 hours ago

      The company is conducting a Phase 1/2 clinical trial of avutometinib plus defactinib in combination with gemcitabine and Nab-paclitaxel. The results were...